TAKEBISHI CORPORATION
TAKEBISHI CORPORATION Q4 FY2025 earnings call
June 3, 2025 · fiscal period ended 2025-03
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2025-06-03
Management highlights
Company Overview
- Takebishi is a Mitsubishi Electric-affiliated technology trading company headquartered in Kyoto, founded in 1926, celebrating its 100th anniversary in 2026. It maintains broad domestic and international supplier and customer networks, with 6 domestic group companies and 4 overseas group companies, including Singapore-based Le Champ (acquired in 2021) with 16 locations across 8 markets including India and Malaysia. Overseas revenue currently accounts for 23% of total revenue.
- The company targets a stable 40/33/27 revenue balance across its three core segments and aims to grow overseas revenue share over time.
Mid-Term Management Plan (T-Link1369)
- The 3-year plan running from FY2024 March to FY2027 March (100th anniversary) targets: 130 billion yen total revenue, 30 billion yen in new business revenue, 6 billion yen ordinary profit, and 9% ROE. The plan focuses on four core growth strategies:
- Global: The 2021 Le Champ acquisition drove initial overseas growth, but ASEAN EMS recovery delays have stalled overall expansion. The company will focus on growing the high-growth Indian market, expand cross-location collaboration across Takebishi Hong Kong, Shanghai, Thailand, and Vietnam to maximize customer response and product sourcing capabilities across ASEAN, and pursue new customer development for Mitsubishi Electric FA equipment in Malaysia.
- Medical: The medical business is growing steadily, driven by rising demand for low-impact radiation cancer therapy amid Japan's aging population. In April 2025, the company expanded its radiation therapy device sales territory from the Kinki region to cover all of Chugoku and Shikoku. It will target replacement demand in the new territory and expand into additional diagnostic devices, surgical/neurosurgical equipment, radiation information systems, and AI-powered medical systems.
- Automation: Dedicated smart factory team founded in 2021 to lead automation business growth. Amid long-term manufacturing labor force decline, demand for factory automation and labor savings is expected to grow. The company will pursue new customer development in semiconductors, decarbonization, and carbon neutrality, expand automation into non-manufacturing sectors, and partner with IT vendors to deliver integrated factory automation proposals leveraging the company's strength as a connector between different technologies.
- Original: Unique proprietary products include DXP Server, an OPC-standard software connecting IT and factory floor data with over 50,000 cumulative sales across 72 countries, and the compass smartphone app for mobile retailers, now being expanded to cross-industry clients including auto dealers and bicycle shops. The company will partner with Le Champ to expand DXP Server sales in India and commercialize AI-integrated solutions for Mitsubishi Electric sequencers currently in pilot testing.
Business Model Transformation
The company is targeting 5 billion yen in additional revenue from new business across four new segments: mobility, materials (magnets and processed goods), energy solutions (expanding solar PV and developing power self-delivery systems for clients), and DX (generic systems for water and sewage infrastructure maintenance leveraging original products, currently deployed to local governments with plans for broader expansion).
Financial Strategy & Capital Efficiency
- The company will actively pursue synergistic M&A to meet mid-term plan targets. It is also refreshing its 20-year-old core enterprise system to support future business scale growth and improve operational efficiency via integration of generative AI, and plans to rebuild its warehouse to strengthen logistics stability.
- Dividend policy targets a progressive dividend with payout ratio of 40% or higher. For FY2026 March, the company plans a 66 yen per share dividend, up 4 yen from the prior year, with a planned payout ratio of 44.1%.
Non-Financial & Sustainability
- The company will expand adoption of solar power generation and self-delivery systems for internal use, then commercialize this expertise for clients to create new business.
- The company will continue to support employee engagement via club activities and internal events to maintain its already low turnover and strong internal connections.
Commercial Events
The company will host its biennial Takebishi Solution Fair in July 2025 (expected 1,500 attendees across three solution zones), exhibit at FOOMA JAPAN to target new food industry business, and Le Champ will exhibit at electronica India to pursue new customer development.
Segment performance
Takebishi's full-year FY2025 (ending March 2025) total revenue was 101 billion yen, with second-half revenue hitting a record 53.4 billion yen. Full-year ordinary profit was 3.8 billion yen, with second-half ordinary profit also reaching a record 2.2 billion yen. The company's product segments performed as follows:
- 産業機器システム (Industrial Equipment Systems): 40% of total revenue contribution. Semiconductor and storage battery-related equipment business grew strongly, but FA (Factory Automation) equipment saw prolonged customer inventory adjustment leading to a 1.5 billion yen year-over-year revenue decrease.
- 半導体・デバイス (Semiconductors & Devices): 33% of total revenue contribution. Electronic component mounting equipment and residential devices grew, and subsidiary Le Champ's Indian business expanded. However, reduced market distribution product sales (following easing of semiconductor/electronic component supply shortages) left full-year results flat year-over-year.
- 社会インフラ (Social Infrastructure): Strong performance from radiation cancer therapy devices driven by solid replacement demand.
- 情報通信 (Information & Communications): Included in the 27% combined revenue contribution for social and information communication segments. Strong sales of high-price terminals at subsidiary Fuji Telecoms and growth from the recently acquired asbestos analysis business drove segment expansion.
Operating profit decreased 310 million yen year-over-year. Positive factors included a 40 million yen yen depreciation gain (led by Le Champ) and a 230 million yen benefit from high-value-added equipment projects and the asbestos analysis business. Offsetting these were a 150 million yen increase in inventory valuation losses from stagnant inventory and a 440 million yen increase in SG&A (from higher personnel costs and M&A expenses).
Guidance
- For FY2026 ending March 2026, Takebishi guides for a new full-year revenue record of 102 billion yen (1 billion yen year-over-year increase), split into 49.1 billion yen for the first half and 52.9 billion yen for the second half. It guides for full-year ordinary profit of 3.8 billion yen, unchanged year-over-year, split into 1.6 billion yen for the first half and 2.2 billion yen for the second half. The guidance already accounts for moderate expected impacts from U.S. tariffs and exchange rate fluctuations.
- Segment guidance for FY2026:
- Industrial Equipment Systems: FA inventory digestion is delayed and the segment outlook remains tight, but growth from renewable energy-related equipment will offset weakness to leave full-year results flat year-over-year. Overall growth is expected from rising customer demand for factory DX amid labor force decline.
- Semiconductors & Devices: Indian business will remain strong, but U.S. tariff and exchange rate impacts will drive a year-over-year revenue decrease.
- Social Infrastructure: Solid replacement demand for radiation cancer therapy devices will drive year-over-year revenue growth.
- Information & Communications: PC replacement demand following the end of Windows 10 support and continued growth from the asbestos analysis business will drive year-over-year revenue growth.
- The mid-term management plan is currently at its midpoint, and overall progress is stalled due to core FA inventory adjustments and lost large industrial mechatronics projects. Management expects growing demand for AI and semiconductor-related FA and devices, as well as infrastructure demand from data center expansion, which the company will capture to get back on plan. Medical and Automation growth strategies are already on track and driving current earnings growth.
Risks
- Prolonged customer inventory adjustment in the core FA equipment segment has delayed mid-term plan progress and driven near-year revenue declines and higher inventory valuation losses.
- ASEAN electronics manufacturing services (EMS) recovery delays have stalled global segment growth following the Le Champ acquisition.
- U.S. tariff policy and foreign exchange rate volatility create headwinds for the international semiconductor and device business, which management has only partially incorporated into guidance.
- Rising personnel costs and M&A-related expenses have increased selling, general and administrative costs, pressuring operating profit margins.
- The core legacy enterprise system is 20 years old and requires full replacement to support future business scale, creating near-term execution risk for the transition.
Q&A highlights
No question and answer section is included in the provided transcript.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
June 3, 2025Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.